FDA Drug recall D-0281-2025
Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme Potency
- FDA Drug
- Class I
- ongoing
- Published 2025-03-26
On 2025-03-26 the FDA classified a Class I recall of Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme Potency by One Source Nutrition, citing marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0281-2025 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2025-02-20 |
| Published | 2025-03-26 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | One Source Nutrition |
| Distribution | US |
Product
Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme Potency.
Reason
Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.
Identifiers
| code_info | All lots |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0281-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.